S
INBX icon

SignatureFD’s Inhibrx INBX Stock Holding History

SignatureFD’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.42K Hold
15
– – ﹤0.01% 3206
2026
Q1 		$1.01K Buy
15
+13
+650% +$964 ﹤0.01% 3210
2025
Q4 		$158 Hold
2
– – ﹤0.01% 3316
2025
Q3 		$67 Hold
2
– – ﹤0.01% 3329
2025
Q2 		$29 Sell
2
-40
-95% -$517 ﹤0.01% 3222
2025
Q1 		$588 Sell
42
-86
-67% -$1.17K ﹤0.01% 3147
2024
Q4 		$1.97K Sell
128
-58
-31% -$883 ﹤0.01% 2874
2024
Q3 		$2.91K Hold
186
– – ﹤0.01% 2728
2024
Q2 		$2.64K Buy
+186
New +$2.91K ﹤0.01% 2689

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SignatureFD's INBX Position: Q2 2026 in Review

SignatureFD held its Inhibrx (INBX) position steady in Q2 2026 at 15 shares worth $1.42K. The position accounts for ﹤0.01% of the portfolio, ranked #3206.

SignatureFD first reported a position in INBX in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.91K in Q3 2024. 162 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • SignatureFD held 15 shares of Inhibrx worth $1.42K as of Q2 2026.
  • SignatureFD left its Inhibrx share count unchanged in Q2 2026.
  • Inhibrx made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #3206 holding.
  • SignatureFD first reported a position in Inhibrx in Q2 2024 and has held it in 9 quarters since.
  • SignatureFD's Inhibrx position peaked at $2.91K in Q3 2024.
  • 162 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.